vs

Side-by-side financial comparison of Beneficient (BENF) and Editas Medicine, Inc. (EDIT). Click either name above to swap in a different company.

Editas Medicine, Inc. is the larger business by last-quarter revenue ($24.7M vs $18.7M, roughly 1.3× Beneficient). Beneficient runs the higher net margin — 106.7% vs -22.7%, a 129.4% gap on every dollar of revenue. On growth, Beneficient posted the faster year-over-year revenue change (322.5% vs -19.2%).

Beneficient is a financial services firm specializing in alternative asset liquidity solutions. It offers tailored options for holders of illiquid alternative investments including private equity, hedge fund stakes, and real assets, serving institutional investors, high-net-worth individuals, and family offices primarily in North America.

Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

BENF vs EDIT — Head-to-Head

Bigger by revenue
EDIT
EDIT
1.3× larger
EDIT
$24.7M
$18.7M
BENF
Growing faster (revenue YoY)
BENF
BENF
+341.7% gap
BENF
322.5%
-19.2%
EDIT
Higher net margin
BENF
BENF
129.4% more per $
BENF
106.7%
-22.7%
EDIT

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
BENF
BENF
EDIT
EDIT
Revenue
$18.7M
$24.7M
Net Profit
$19.9M
$-5.6M
Gross Margin
Operating Margin
21.1%
-31.3%
Net Margin
106.7%
-22.7%
Revenue YoY
322.5%
-19.2%
Net Profit YoY
330.5%
87.6%
EPS (diluted)
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BENF
BENF
EDIT
EDIT
Q4 25
$18.7M
$24.7M
Q3 25
$-2.8M
$7.5M
Q2 25
$-12.6M
$3.6M
Q1 25
$-31.0M
$4.7M
Q4 24
$4.4M
$30.6M
Q3 24
$8.6M
$61.0K
Q2 24
$10.0M
$513.0K
Q1 24
$1.1M
Net Profit
BENF
BENF
EDIT
EDIT
Q4 25
$19.9M
$-5.6M
Q3 25
$-17.9M
$-25.1M
Q2 25
$-92.6M
$-53.2M
Q1 25
$-44.6M
$-76.1M
Q4 24
$-8.6M
$-45.4M
Q3 24
$9.7M
$-62.1M
Q2 24
$44.3M
$-67.6M
Q1 24
$-62.0M
Operating Margin
BENF
BENF
EDIT
EDIT
Q4 25
21.1%
-31.3%
Q3 25
646.5%
-325.4%
Q2 25
734.0%
-1440.6%
Q1 25
146.3%
-1635.1%
Q4 24
-215.3%
-152.2%
Q3 24
-160.2%
-107649.2%
Q2 24
-14016.2%
Q1 24
-5902.3%
Net Margin
BENF
BENF
EDIT
EDIT
Q4 25
106.7%
-22.7%
Q3 25
648.1%
-333.0%
Q2 25
734.0%
-1487.8%
Q1 25
144.1%
-1633.5%
Q4 24
-195.5%
-148.3%
Q3 24
113.9%
-101870.5%
Q2 24
441.1%
-13178.8%
Q1 24
-5458.1%
EPS (diluted)
BENF
BENF
EDIT
EDIT
Q4 25
$0.03
Q3 25
$-0.28
Q2 25
$-0.63
Q1 25
$-0.92
Q4 24
$-0.55
Q3 24
$-0.75
Q2 24
$-0.82
Q1 24
$-0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BENF
BENF
EDIT
EDIT
Cash + ST InvestmentsLiquidity on hand
$7.9M
$146.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$-128.6M
$27.3M
Total Assets
$337.9M
$186.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BENF
BENF
EDIT
EDIT
Q4 25
$7.9M
$146.6M
Q3 25
$4.9M
$165.6M
Q2 25
$7.6M
$178.5M
Q1 25
$1.3M
$221.0M
Q4 24
$4.1M
$269.9M
Q3 24
$4.5M
$265.1M
Q2 24
$4.4M
$279.1M
Q1 24
$296.2M
Total Debt
BENF
BENF
EDIT
EDIT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$57.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BENF
BENF
EDIT
EDIT
Q4 25
$-128.6M
$27.3M
Q3 25
$-142.8M
$13.5M
Q2 25
$-120.4M
$19.2M
Q1 25
$-34.9M
$62.4M
Q4 24
$14.3M
$134.3M
Q3 24
$-13.2M
$175.6M
Q2 24
$-148.3M
$232.0M
Q1 24
$294.4M
Total Assets
BENF
BENF
EDIT
EDIT
Q4 25
$337.9M
$186.5M
Q3 25
$316.2M
$201.8M
Q2 25
$334.5M
$210.6M
Q1 25
$354.9M
$263.7M
Q4 24
$400.0M
$341.6M
Q3 24
$368.8M
$327.6M
Q2 24
$361.3M
$384.8M
Q1 24
$440.3M
Debt / Equity
BENF
BENF
EDIT
EDIT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.43×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BENF
BENF
EDIT
EDIT
Operating Cash FlowLast quarter
$-9.4M
$-36.4M
Free Cash FlowOCF − Capex
$-36.4M
FCF MarginFCF / Revenue
-147.3%
Capex IntensityCapex / Revenue
0.0%
0.2%
Cash ConversionOCF / Net Profit
-0.47×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BENF
BENF
EDIT
EDIT
Q4 25
$-9.4M
$-36.4M
Q3 25
$-14.5M
$-30.8M
Q2 25
$-10.8M
$-50.2M
Q1 25
$-37.7M
$-47.8M
Q4 24
$-10.0M
$-50.8M
Q3 24
$-8.6M
$-52.6M
Q2 24
$-10.6M
$-57.1M
Q1 24
$-49.9M
Free Cash Flow
BENF
BENF
EDIT
EDIT
Q4 25
$-36.4M
Q3 25
$-31.3M
Q2 25
$-10.9M
Q1 25
$-38.8M
$-47.9M
Q4 24
$-10.0M
$-51.3M
Q3 24
$-8.9M
$-55.5M
Q2 24
$-11.3M
$-60.6M
Q1 24
$-51.7M
FCF Margin
BENF
BENF
EDIT
EDIT
Q4 25
-147.3%
Q3 25
-414.6%
Q2 25
86.6%
Q1 25
125.3%
-1028.6%
Q4 24
-227.2%
-167.6%
Q3 24
-103.7%
-90998.4%
Q2 24
-112.6%
-11804.3%
Q1 24
-4558.9%
Capex Intensity
BENF
BENF
EDIT
EDIT
Q4 25
0.0%
0.2%
Q3 25
0.0%
5.7%
Q2 25
-0.8%
0.0%
Q1 25
-3.5%
2.4%
Q4 24
1.0%
1.8%
Q3 24
3.1%
4788.5%
Q2 24
6.6%
681.1%
Q1 24
164.8%
Cash Conversion
BENF
BENF
EDIT
EDIT
Q4 25
-0.47×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-0.88×
Q2 24
-0.24×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BENF
BENF

Ben Liquidity$8.2M44%
Other$7.6M41%
Ben Custody$2.9M16%

EDIT
EDIT

Segment breakdown not available.

Related Comparisons